Patents Assigned to AFGIN Pharma LLC
-
Publication number: 20210259957Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a drug to the back of the neck of a human patient at the hairline in close proximity to and under or on the area of skin above the brain stem to provide regional neuro-affective therapy is disclosed.Type: ApplicationFiled: May 7, 2021Publication date: August 26, 2021Applicant: AFGIN PHARMA, LLCInventor: Ronald Aung-Din
-
Patent number: 10828266Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of caryophyllene to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream, gel, lotion or foam.Type: GrantFiled: May 22, 2019Date of Patent: November 10, 2020Assignee: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Patent number: 10716766Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the cannabinoid drug(s) are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: GrantFiled: March 2, 2016Date of Patent: July 21, 2020Assignee: AfGin Pharma, LLCInventor: Ronald Aung-Din
-
Patent number: 10632064Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) and a second therapeutically active agent(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: GrantFiled: July 9, 2019Date of Patent: April 28, 2020Assignee: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20190343760Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) and a second therapeutically active agent(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: July 9, 2019Publication date: November 14, 2019Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20190274969Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of caryophyllene to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream, gel, lotion or foam.Type: ApplicationFiled: May 22, 2019Publication date: September 12, 2019Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Patent number: 10383816Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) and a second therapeutically active agent(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: GrantFiled: November 15, 2018Date of Patent: August 20, 2019Assignee: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20190083387Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) and a second therapeutically active agent(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: November 15, 2018Publication date: March 21, 2019Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20190060222Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a drug to the back of the neck of a human patient at the hairline in close proximity to and under or on the area of skin above the brain stem to provide regional neuro-affective therapy is disclosed.Type: ApplicationFiled: October 29, 2018Publication date: February 28, 2019Applicant: AFGIN PHARMA, LLCInventor: Ronald Aung-Din
-
Patent number: 10172809Abstract: A method of treating a disease state or condition in mammals other than humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) to the back of the neck region and/or spine to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the cannabinoid drug(s) are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream or mousse. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: GrantFiled: July 12, 2018Date of Patent: January 8, 2019Assignee: AFGIN PHARMA LLCInventor: Ronald Aung-Din
-
Publication number: 20180318237Abstract: A method of treating a disease state or condition in mammals other than humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) to the back of the neck region and/or spine to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the cannabinoid drug(s) are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream or mousse. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: July 12, 2018Publication date: November 8, 2018Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20180049994Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of caryophyllene to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream, gel, lotion or foam.Type: ApplicationFiled: August 16, 2016Publication date: February 22, 2018Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20170266128Abstract: A method of treating a disease state or condition in mammals other than humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) to the back of the neck region and/or spine to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the cannabinoid drug(s) are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream or mousse. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: June 2, 2017Publication date: September 21, 2017Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20160338974Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) and a second therapeutically active agent(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the drugs are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: August 4, 2016Publication date: November 24, 2016Applicant: Afgin Pharma, LLCInventor: Ronald Aung-Din
-
Publication number: 20160256411Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) to the back of the neck of a human patient to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the cannabinoid drug(s) are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: March 2, 2016Publication date: September 8, 2016Applicant: Afgin Pharma, LLCInventor: Ronald AUNG-DIN
-
Publication number: 20160256410Abstract: A method of treating a disease state or condition in mammals other than humans via topical brainstem afferent stimulation therapy via the administration of a cannabinoid drug(s) to the back of the neck region and/or spine to provide regional neuro-affective therapy is disclosed. In certain preferred embodiments, the cannabinoid drug(s) are not psychoactive or substantially not psychoactive. In certain embodiments, the cannabinoid drug(s) are incorporated into a pharmaceutically acceptable topical carrier, e.g., a cream or mousse. In certain preferred embodiments, the cannabinoid drug(s) comprises cannabidiol.Type: ApplicationFiled: March 2, 2016Publication date: September 8, 2016Applicant: Afgin Pharma, LLCInventor: Ronald AUNG-DIN
-
Publication number: 20160058752Abstract: Formulations and methods of treating peripheral neuropathic conditions in humans is disclosed.Type: ApplicationFiled: February 27, 2015Publication date: March 3, 2016Applicant: AFGIN PHARMA, LLCInventor: Ronald Aung-Din
-
Publication number: 20150111930Abstract: A method of treating a disease state or condition in humans via topical brainstem afferent stimulation therapy via the administration of a drug to the back of the neck of a human patient at the hairline in close proximity to and under or on the area of skin above the brain stem to provide regional neuro-affective therapy is disclosed.Type: ApplicationFiled: October 23, 2013Publication date: April 23, 2015Applicant: AFGIN PHARMA, LLCInventor: Ronald Aung-Din
-
Patent number: 9012480Abstract: The invention is directed to formulations and methods of treating a migraine and/or cluster headache with a serotonin agonist, pharmaceutically acceptable salt thereof, or derivative thereof.Type: GrantFiled: December 7, 2012Date of Patent: April 21, 2015Assignee: AFGIN Pharma LLCInventor: Ronald Aung-Din
-
Patent number: 8883830Abstract: The invention is directed to topical formulations and methods of treating a migraines and/or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related migraines and related conditions associated with muscle tension and pain with a therapeutically effective amount of an ergot alkaloid, skeletal muscle relaxant, serotonin agonist, combinations thereof, pharmaceutically acceptable salt thereof, prodrugs thereof or derivative thereof.Type: GrantFiled: January 13, 2012Date of Patent: November 11, 2014Assignee: Afgin Pharma LLC.Inventor: Ronald Aung-Din